NextCell Pharma
3.32
SEK
-4.05 %
Less than 1K followers
NXTCL
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
-4.05%
-1.19%
+16.9%
+64.36%
+125.85%
+42%
-38.64%
-3.58%
+50.13%
NextCell Pharma operates in the healthcare sector. Today, development is carried out of stem cell products mainly used in the treatment of autoimmune diabetes and for kidney transplants. A significant part of the work consists of stem cell research where the company develops drug candidates that should enable and increase the acceptance of organ transplants. In addition, the company has a stem cell bank. The company was established in 2014 and is based in Huddinge.
Read moreMarket cap
242.66M SEK
Turnover
1.43M SEK
Revenue
10.66M
EBIT %
-404.97 %
P/E
-
Dividend yield-%
-
Financial calendar
25.4
2025
Interim report Q2'25
24.7
2025
Interim report Q3'25
30.10
2025
Annual report '25
All
Press releases
ShowingAll content types
NextCell Pharma AB: All Patients with Severe Virus-Induced Pneumonia Treated in the ProTrans V Study
Redeye: Redeye Initiates Coverage of NextCell Pharma
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools